Clinical Trials: A Phase I Trial of Vorinostat in Combination With Bevacizumab and Irinotecan in Recurrent Glioblastoma

Sponsor and Collaborators

H. Lee Moffitt Cancer Center and Research Institute

Merck

Contact

Pam Smith

813-745-3951

pam.smith@moffitt.org

Principal Investigator

Prakash Chinnaiyan, MD, H. Lee Moffitt Cancer Center & Research Institute, Inc.

ClinicalTrials.gov Identifier

NCT00762255

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs